Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib

IMPORTANCE: Cabozantinib S-malate is a vascular endothelial growth factor receptor 2, c-MET, and RET multitargeted tyrosine kinase inhibitor that has antiangiogenic and antitumorigenic properties with potential efficacy for the treatment of several cancers. Cutaneous reactions, one of the most frequ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA Dermatol
Päätekijät: Zuo, Rena C., Apolo, Andrea B., DiGiovanna, John J., Parnes, Howard L., Keen, Corrine M., Nanda, Swati, Dahut, William L., Cowen, Edward W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776420/
https://ncbi.nlm.nih.gov/pubmed/25427282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2014.2734
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia